ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Estrella Immunopharma Inc

Estrella Immunopharma Inc (ESLA)

1,17
0,00
(0,00%)
Fermé 27 Décembre 10:00PM
1,20
0,03
(2,56%)
Après les heures de négociation: 1:59AM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
1,17
Prix Achat
1,15
Prix Vente
1,29
Volume échangé
28 778
1,06 Fourchette du Jour 1,29
0,63 Plage de 52 semaines 3,23
Cap du marché
Clôture Veille
1,17
Ouverture
1,24
Dernière Transaction
138
@
1.17
Dernière heure de transaction
Volume financier
US$ 35 598
VWAP
1,237
Volume moyen (3 m)
39 509
Actions en circulation
36 179 147
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-5,94
Bénéfice par action (BPA)
-0,2
Chiffre d'affairess
-
Bénéfice net
-7,31M

À propos de Estrella Immunopharma Inc

TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Siège social
Wilmington, Delaware, USA
Fondé
-
Estrella Immunopharma Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker ESLA. Le dernier cours de clôture d'Estrella Immunopharma était de US$1,17. Au cours de la dernière année, les actions de Estrella Immunopharma ont été négociées dans une fourchette de prix de US$ 0,63 à US$ 3,23.

Estrella Immunopharma compte actuellement 36 179 147 actions en circulation. La capitalisation boursière d'Estrella Immunopharma est de US$42,33 million. Estrella Immunopharma a un ratio cours/bénéfice (ratio PE) de -5.94.

ESLA Dernières nouvelles

Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) (“Estrella” or the “Company”), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat...

Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) ("Estrella", “Estrella Immunopharma”, or the "Company"), a clinical stage biopharmaceutical company focused on developing CD19 and CD22-targeted...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.02-1.680672268911.191.291.02141651.13850648CS
40.065.405405405411.111.4851.02603381.28553591CS
12-0.03-2.51.21.4850.63395091.07657405CS
260.2425.80645161290.933.230.631173901.47738608CS
520.010.8620689655171.163.230.63738981.4053221CS
156-4.04-77.54318618045.215.620.63773341.55863201CS
260-4.04-77.54318618045.215.620.63773341.55863201CS

ESLA - Frequently Asked Questions (FAQ)

What is the current Estrella Immunopharma share price?
The current share price of Estrella Immunopharma is US$ 1,17
How many Estrella Immunopharma shares are in issue?
Estrella Immunopharma has 36 179 147 shares in issue
What is the market cap of Estrella Immunopharma?
The market capitalisation of Estrella Immunopharma is USD 42,33M
What is the 1 year trading range for Estrella Immunopharma share price?
Estrella Immunopharma has traded in the range of US$ 0,63 to US$ 3,23 during the past year
What is the PE ratio of Estrella Immunopharma?
The price to earnings ratio of Estrella Immunopharma is -5,94
What is the reporting currency for Estrella Immunopharma?
Estrella Immunopharma reports financial results in USD
What is the latest annual profit for Estrella Immunopharma?
The latest annual profit of Estrella Immunopharma is USD -7,31M
What is the registered address of Estrella Immunopharma?
The registered address for Estrella Immunopharma is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801
Which industry sector does Estrella Immunopharma operate in?
Estrella Immunopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AIREreAlpha Tech Corporation
US$ 3,5701
(160,59%)
130,88M
SPRCSciSparc Ltd
US$ 0,50
(126,04%)
239,51M
ZCARZoomcar Holdings Inc
US$ 2,80
(95,80%)
60,3M
MGIHMillennium Group International Holdings Ltd
US$ 2,9698
(94,10%)
75,35M
SKKSKK Holdings Limited
US$ 1,35
(80,48%)
52,11M
LNKSLinkers Industries Ltd
US$ 3,295
(-65,64%)
3,65M
GTIGraphjet Technology
US$ 0,3354
(-45,02%)
22,44M
BAOSBaosheng Media Group Holdings Ltd
US$ 4,3979
(-38,06%)
1,97M
NEUPNeuphoria Therapeutics Inc
US$ 4,34
(-34,54%)
599,97k
SVRESaverOne 2014 Ltd
US$ 1,0501
(-30,46%)
1,36M
XTIAXTI Aerospace Inc
US$ 0,0398
(1,53%)
270,76M
SPRCSciSparc Ltd
US$ 0,50
(126,04%)
239,51M
COEPCoeptis Therapeutics Holdings Inc
US$ 0,213249
(50,18%)
205,2M
RGTIRigetti Computing Inc
US$ 15,445
(36,08%)
204,3M
SMXSMX Security Matters Public Company
US$ 0,3303
(51,51%)
172,17M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées